Investors.kannalife.com is a subdomain of kannalife.com, which was created on 2010-05-09,making it 14 years ago.
Description:KannaLife Sciences, Inc. is a bio-pharmaceutical and phyto-medical company involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as...
Keywords:#6630507, 6630507, USPATENT6630507, phyto, medical, pharmaceutical, biotechnology, botanical,...
Discover investors.kannalife.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 50.656 KB |
Page Load Time: 0.570315 Seconds |
Website IP Address: 104.154.134.76 |
Investor Relations :: CNS Pharmaceuticals, Inc. (CNSP) |
Mirum Pharmaceuticals, Inc. - Investor Relations |
PHYTO - International - The power of botanics |
Brain Exercises, Brain Training, Brain Health – BrainHQ from Posit Science |
Ironwood Pharmaceuticals, Inc. - Company Overview |
ISH Data :: Allen Brain Atlas: Mouse Brain |
McKesson | Medical Supplies, Pharmaceuticals Healthcare Solutions |
Picture Book Brain Trust - Picture Book Brain Trust |
Lifeline Pharmaceuticals, LLC’s Login Page | Lifeline Pharmaceuticals, LLC |
Total Brain Blog - Self Monitoring and Self Care Brain Optimization Platform |
IEEE Brain | Neuroscience News, Events, and Research – IEEE Brain Initiative |
NeuroNation - The Blog about Brain Training & Brain |
Developing Pharmaceuticals to Protect the Brain: Neuropathix ... https://investors.kannalife.com/ |
Kannalife, Inc. Appoints Dr. Tage Honoré as Chairman of the Company's ... http://investors.kannalife.com/prviewer/release_only/id/4458916 |
Kannalife, Inc. Bolsters IP Portfolio with Multiple Patents Issued in ... https://investors.kannalife.com/prviewer/release_only/id/4370998 |
Neuropathix, Inc. - A Phyto-Medical Company | Developing ... https://investors.kannalife.com/KLFE/stock_quote |
Kannalife, Inc. Receives Seventh Patent by Extending Patent Family to ... http://investors.kannalife.com/prviewer/release_only/id/4264362 |
Kannalife Inc. Publishes New Research on Chemotherapy-Induced ... http://investors.kannalife.com/prviewer/release_only/id/3824234 |
Kannalife, Inc. Receives Patent Grants in Additional European Territories http://investors.kannalife.com/prviewer/release_only/id/4433704 |
Kannalife, Inc. CEO Featured in OTCQB Podcast Discussing KLS-13019 and ... http://investors.kannalife.com/prviewer/release_only/id/4292466 |
Kannalife, Inc. Receives Notice of Allowance from USPTO for Trademark ... http://investors.kannalife.com/prviewer/release_only/id/4278031 |
PDF Financial Tearsheet https://investors.kannalife.com/template_files/1360/tearsheet_pdf.pdf |
Kannalife Spokesman Nick Lowery Wins 2018 CNBC Stock Draft http://investors.kannalife.com/prviewer/release_only/id/3607310 |
Server: nginx |
Date: Tue, 14 May 2024 22:38:31 GMT |
Content-Type: text/html |
Transfer-Encoding: chunked |
Connection: keep-alive |
Vary: Accept-Encoding, Accept-Encoding |
Set-Cookie: ci_session=T8BmeK2B%2FO4alHQgmEuJan%2BhriLPOnp74tjCKkoqENrdjZXOTU%2FxnIUmb%2BddOMqHgBLDF31iUyZJpCnumK9O5pW7rRQlbbmkL%2FiS7UxyMRAM%2BFVUhNds6fNfuEOVEeQpUn55rm0mavMvmijMmRuvT1rVHNhxhxOJWDailf%2BNxgyrpRof4k3Ai%2FyB0I1CCWIpwmjedW7EP4HrgH35MN%2FUfdkha0PInvXd1OcNDlWYMkKJvC7ottjqJTldYCOGvJDNvvrhElQIkEGg8RrBCm2UPFGUQl3UR1zQywE41TPrKjOz%2BfDVS4eZcVYQZ6RZSZziwiDXj5ofVGnew1QJTsrdTg%3D%3D; expires=Wed, 15-May-2024 00:38:31 GMT; path=/ |
Expires: Tue, 14 May 2024 22:38:31 GMT |
Last-Modified: Tue, 14 May 2024 22:38:31 GMT |
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0 |
Pragma: no-cache |
X-Request-ID: b1fad446bf8d599b53d070b02a053db8 |
X-Cache: EXPIRED |
charset="utf-8"/ |
content="width=device-width" name="viewport"/ |
content="KannaLife Sciences, Inc. is a bio-pharmaceutical and phyto-medical company involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. KannaLife Sciences currently holds an exclusive license with National Institutes of Health – Office of Technology Transfer (NIH-OTT) for the Commercialization of U.S. Patent 6,630,507, Cannabinoids as Antioxidants and Neuroprotectants (the 507 Patent). KannaLife is currently conducting research and development at the Bucks County Biotechnology Center in Doylestown, PA, for a target drug candidate to treat Hepatic Encephalopathy (HE). HE is an oxidative stress related disease that affects the cognitive and behavioral functions, and the wellness of the brain. #6630507, 6630507" name="description" |
content="#6630507, 6630507, USPATENT6630507, phyto, medical, pharmaceutical, biotechnology, botanical, medicine, cannabis, cannabinoids, endocannabinoids, antioxidants, neuroprotectants, phytocannabinoids, phytopharmaceutical, terpene, terpenes, cannatol, kannalife, cannalife, kannabis, government patent on cannabinoids, cannabinoid patent, cannabinol, CBN, cannabidiol, CBD, cannabigerol, CBG, cannabichromene, CBC, tetrahydrocannabinol, tetrahydrocannabivarin, THCV, cannabicyclol, CBL, cannabivarin, CBV, cannabicitran, CBT, cannabidivarin, CBDV, cannabichromevarin, CBCV, cannabigerovarin, CBGV, cannabigerol monomethyl ether, CBGM, Arachidonoylethanolamine, AEA, anandamide, 2-arachidonoyl glycerol, 2-AG, 2-arachidonyl glyceryl ether, noladin ether, N-arachidonoyl-dopamine, NADA, virodhamine, OAE, lysophosphatidylinositol, LPI, novel therapeutics" name="keywords" |
content="web" name="distribution"/ |
Ip Country: United States |
City Name: Council Bluffs |
Latitude: 41.2591 |
Longitude: -95.8517 |
Leadership Science Investors IR Kit Tear Sheet Press Releases Stock Quotes SEC Filings Key Contacts Subscribe to Email Alerts News Contact Home About Leadership Science Investors IR Kit Tear Sheet Press Releases Stock Information SEC Filings Key Contacts Subscribe to Email Alerts News Contact Stay Ahead | | Search for: Overview Symbol NPTX Price Delayed by 20 minutes IR Nav Overview IR Kit Tear Sheet Press Releases Stock Information SEC Filings Key Contacts Subscribe to Email Alerts Tear Sheet IR Contacts Subscribe to News Alerts RSS Feed Company Profile Pennsylvania Biotechnology Center 3805 Old Easton Road Doylestown, PA 18902 (215) 695-6559 (516) 960-9212 info@kannalife.com Leadership View Management Team Recent News & Filings News View All News Articles Filings View All Filings Latest 10-K Latest 10-Q Investor Relations Investor Relations Firm CORE IR 377 Oak Street Garden City, NY 11530 (516) 222-2285 www.coreir.com Contact: John Marco Johnm@coreir.com Transfer Agent Securities Transfer Corp. 2901 Dallas Parkway, Suite 380, Plano, TX 75093 (469) 633-0101 www.stctransfer.com Auditors DBB McKennon 12790 El Camino Real #130 San Diego, CA 92130 (858) 217-4035 www.dbbmckennon.com Corporate Counsel Procopio, Cory, Hargreaves & Savitch LLP. 525 B Street, Suite 2200 San Diego, CA 92101 (619) 238-1900 www.procopio.com Click here to get the latest in Neuropathix, Inc. News Home About Leadership Science Investors IR Kit Tear Sheet Press Releases Stock Quotes SEC Filings Key Contacts Subscribe to Email Alerts News Contact Copyright © 2024 Neuropathix, Inc. All rights...
Domain Name: KANNALIFE.COM Registry Domain ID: 1596486413_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2023-05-09T03:18:57Z Creation Date: 2010-05-09T18:51:51Z Registry Expiry Date: 2028-05-09T18:51:51Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS07.DOMAINCONTROL.COM Name Server: NS08.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T23:35:39Z <<<